Schering Plough has announced the launch of a new addition to its Claritin allergy range, called Liqui-Gels.
The liquid-filled capsules - which have been produced to deliver relief from allergy symptoms - are the first to offer the medicine in this form without causing drowsiness, according to the company.
Liqui-Gels have been approved for adults and children over the age of six and are available without a prescription. Their launch follows a recent survey which found 75 per cent of liquid-filled capsule consumers preferred them over tablets.
Dr John O'Mullane, group vice-president of research and development at Schering-Plough Consumer Health Care, said the new product is "the latest advancement for the 50 million Americans who suffer from allergies".
He added: "We are pleased to bring this innovative form to the line of non-drowsy Claritin products."
Last month, Schering Plough announced the European Authorisation Agency accepted for review its Marketing Authorisation Application for its sustained follicle stimulant, corifollitropin alfa.See all the latest jobs in Pharmaceutical